Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Lapatinib Plus Carboplatin and Paclitaxel in Stage III or IV Relapsed Ovarian or Stage IV Breast Cancer Patients

NCT00316407 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT00316407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Lapatinib Plus Carboplatin and Paclitaxel in Stage III or IV Relapsed Ovarian or Stage IV Breast Cancer Patients
Lead sponsor
Swedish Medical Center
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2005
Completion date
November 30, 2009
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian epithelial cancer stage iii, stage iv breast cancer, stage iv ovarian cancer